{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:25:38Z","timestamp":1789676738571,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>An online 3-item survey was sent to the European Academy of Neurology (EAN) community and inquired about the persistence of SARS-CoV-2 vaccination skepticism and the underlying thoughts and factors restricting vaccine use among patients with neurological conditions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We obtained 616 responses from 84 countries, predominantly from Europe. In the view of the treating neurologist, patients with multiple sclerosis (MS), neuroimmunological disorders (ND), and chronic neurological infections continued to have high levels of skepticism toward SARS-CoV-2 vaccination. Patients with MS\/ND were quoted as the most hesitant group, with 60% of the respondents sharing this impression. The patient group perceived as most confident towards immunization against COVID-19 and with the lowest level of distrust towards the vaccine were those with sleep disorders. For all other conditions, perceived distrust ranged between 42 and 52%. Fear of adverse events of vaccination or disease reactivation was perceived by 87% of patients with MS\/ND and more than 70% of patients with stroke\/vascular neurology, neuromuscular disorders, chronic neurological infections, and peripheral neuropathy. Patients with sleep disorders (54%), autonomic disorders (46%), movement disorders (43%), and dementia (43%) were sensed as less fearful of vaccine-related adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite the large body of evidence proving the efficacy and safety of SARS-CoV-2 vaccination, patients with certain neurological disorders still have a surprisingly high percentage of distrust and fear of adverse events. Our observations emphasize the importance of continuous evidence-based information delivery and patient education by treating neurologists.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10072-025-08017-w","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:11:12Z","timestamp":1738649472000},"page":"1467-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease\u2013 a survey of the NeuroCOVID-19 task force of the European Academy of Neurology"],"prefix":"10.1007","volume":"46","author":[{"given":"Sonja","family":"Hochmeister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rakusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cavallieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u0161a R.","family":"Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Guekht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Helbok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Martinelli","family":"Boneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serefnur","family":"\u00d6zturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dauren","family":"Ramankulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-5533","authenticated-orcid":false,"given":"Johann","family":"Sellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"8017_CR1","unstructured":"News UN WHO chief declares end to COVID-19 as a global health emergency 2023 [April 4 2024]. Available from: https:\/\/news.un.org\/en\/story\/2023\/05\/1136367"},{"key":"8017_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/ene.15087","volume":"29","author":"B Bodini","year":"2022","unstructured":"Bodini B, Moro E, Jaarsma J, Cunningham E, Sellner J, Walsh D et al (2022) Lessons learned from people with neurological diseases at the time of COVID-19: the EFNA-EAN survey. Eur J Neurol 29:318\u2013323. https:\/\/doi.org\/10.1111\/ene.15087","journal-title":"Eur J Neurol"},{"key":"8017_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15787","author":"A Fanciulli","year":"2023","unstructured":"Fanciulli A, Leys F, Krbot Skoric M, Carneiro DR, Calandra-Buonaura G, Camaradou J et al (2023) Impact of the COVID-19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology (EAN) and the European Federation of Autonomic Societies (EFAS). Eur J Neurol:Online Ahead Print. https:\/\/doi.org\/10.1111\/ene.15787","journal-title":"Eur J Neurol:Online Ahead Print"},{"key":"8017_CR4","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/ene.14257","volume":"27","author":"J Sellner","year":"2020","unstructured":"Sellner J, Taba P, Ozturk S, Helbok R (2020) The need for neurologists in the care of COVID-19 patients. Eur J Neurol 27:e31\u2013e2. https:\/\/doi.org\/10.1111\/ene.14257","journal-title":"Eur J Neurol"},{"key":"8017_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-323-91532-8.00004-5","volume":"189","author":"F Cavallieri","year":"2022","unstructured":"Cavallieri F, Sellner J, Zedde M, Moro E (2022) Neurologic complications of coronavirus and other respiratory viral infections. Handb Clin Neurol 189:331\u2013358. https:\/\/doi.org\/10.1016\/B978-0-323-91532-8.00004-5","journal-title":"Handb Clin Neurol"},{"key":"8017_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/brain\/awac332","volume":"146","author":"SM Cho","year":"2023","unstructured":"Cho SM, White N, Premraj L, Battaglini D, Fanning J, Suen J et al (2023) Neurological manifestations of COVID-19 in adults and children. Brain 146:1648\u20131661. https:\/\/doi.org\/10.1093\/brain\/awac332","journal-title":"Brain"},{"key":"8017_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13365-020-00918-0","volume":"27","author":"M Ghaffari","year":"2021","unstructured":"Ghaffari M, Ansari H, Beladimoghadam N, Aghamiri SH, Haghighi M, Nabavi M et al (2021) Neurological features and outcome in COVID-19: dementia can predict severe disease. J Neurovirol 27:86\u201393. https:\/\/doi.org\/10.1007\/s13365-020-00918-0","journal-title":"J Neurovirol"},{"key":"8017_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fneur.2020.00781","volume":"11","author":"D Garcia-Azorin","year":"2020","unstructured":"Garcia-Azorin D, Martinez-Pias E, Trigo J, Hernandez-Perez I, Valle-Penacoba G, Talavera B et al (2020) Neurological comorbidity is a predictor of death in Covid-19 Disease: a Cohort Study on 576 patients. Front Neurol 11:781. https:\/\/doi.org\/10.3389\/fneur.2020.00781","journal-title":"Front Neurol"},{"key":"8017_CR9","doi-asserted-by":"publisher","first-page":"e0249920","DOI":"10.1371\/journal.pone.0249920","volume":"16","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Wu G, Primakov S, Oberije C, Woodruff H, Kubben P et al (2021) Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: an externally validated study. PLoS ONE 16:e0249920. https:\/\/doi.org\/10.1371\/journal.pone.0249920","journal-title":"PLoS ONE"},{"key":"8017_CR10","doi-asserted-by":"publisher","first-page":"e3066","DOI":"10.1002\/brb3.3066","volume":"13","author":"S Lindemann","year":"2023","unstructured":"Lindemann S, Bohm M, Gonnert F, Bosel J, Schubert R, Musleh R et al (2023) Impact of new-onset and preexisting neurological disorders in COVID-19 patients. Brain Behav 13:e3066. https:\/\/doi.org\/10.1002\/brb3.3066","journal-title":"Brain Behav"},{"key":"8017_CR11","doi-asserted-by":"publisher","first-page":"e16168","DOI":"10.1111\/ene.16168","volume":"31","author":"M Rakusa","year":"2024","unstructured":"Rakusa M, Moro E, Akhvlediani T, Bereczki D, Bodini B, Cavallieri F et al (2024) The COVID-19 pandemic and neurology: a survey on previous and continued restrictions for clinical practice, curricular training, and health economics. Eur J Neurol 31:e16168. https:\/\/doi.org\/10.1111\/ene.16168","journal-title":"Eur J Neurol"},{"key":"8017_CR12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/ene.15368","volume":"29","author":"M Rakusa","year":"2022","unstructured":"Rakusa M, Ozturk S, Moro E, Helbok R, Bassetti CL, Beghi E et al (2022) COVID-19 vaccination hesitancy among people with chronic neurological disorders: a position paper. Eur J Neurol 29:2163\u20132172. https:\/\/doi.org\/10.1111\/ene.15368","journal-title":"Eur J Neurol"},{"key":"8017_CR13","first-page":"E47","volume":"57","author":"R Rosselli","year":"2016","unstructured":"Rosselli R, Martini M, Bragazzi NL (2016) The old and the new: vaccine hesitancy in the era of the web 2.0. Challenges and opportunities. J Prev Med Hyg 57:E47\u201350","journal-title":"J Prev Med Hyg"},{"key":"8017_CR14","doi-asserted-by":"publisher","first-page":"20018","DOI":"10.1038\/s41598-022-21434-7","volume":"12","author":"YSG Hoffman","year":"2022","unstructured":"Hoffman YSG, Levin Y, Palgi Y, Goodwin R, Ben-Ezra M, Greenblatt-Kimron L (2022) Vaccine hesitancy prospectively predicts nocebo side-effects following COVID-19 vaccination. Sci Rep 12:20018. https:\/\/doi.org\/10.1038\/s41598-022-21434-7","journal-title":"Sci Rep"},{"key":"8017_CR15","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/ene.14713","volume":"28","author":"J Sellner","year":"2021","unstructured":"Sellner J, Jenkins TM, von Oertzen TJ, Bassetti CL, Beghi E, Bereczki D et al (2021) Primary prevention of COVID-19: advocacy for vaccination from a neurological perspective. Eur J Neurol 28:3226\u20133229. https:\/\/doi.org\/10.1111\/ene.14713","journal-title":"Eur J Neurol"},{"key":"8017_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1212\/WNL.0000000000012578","volume":"97","author":"EB Marsh","year":"2021","unstructured":"Marsh EB, Kornberg M, Kessler K, Haq I, Patel AD, Nath A et al (2021) COVID-19 and vaccination in the setting of neurologic disease: an emerging issue in Neurology. Neurology 97:720\u2013728. https:\/\/doi.org\/10.1212\/WNL.0000000000012578","journal-title":"Neurology"},{"key":"8017_CR17","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.3346\/jkms.2022.37.e325","volume":"37","author":"E Nham","year":"2022","unstructured":"Nham E, Kim YE, Jung J, Kim DW, Jang H, Hyun H et al (2022) COVID-19 vaccination rates in patients with Chronic Medical conditions: a nationwide cross-sectional study. J Korean Med Sci 37:e325. https:\/\/doi.org\/10.3346\/jkms.2022.37.e325","journal-title":"J Korean Med Sci"},{"key":"8017_CR18","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/S2665-9913(","volume":"3","author":"L Boekel","year":"2021","unstructured":"Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J et al (2021) Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet Rheumatol 3:e241\u2013e3. https:\/\/doi.org\/10.1016\/S2665-9913(21)00037\u2013\u20090","journal-title":"Lancet Rheumatol"},{"key":"8017_CR19","doi-asserted-by":"publisher","first-page":"104102","DOI":"10.1016\/j.msard.2022.104102","volume":"65","author":"JS Lechner-Scott","year":"2022","unstructured":"Lechner-Scott JS, Davis JS, Hawkes C, Giovannoni G, Levy M, Yeh A (2022) Vaccine hesitancy in people with multiple sclerosis. Mult Scler Relat Disord 65:104102. https:\/\/doi.org\/10.1016\/j.msard.2022.104102","journal-title":"Mult Scler Relat Disord"},{"key":"8017_CR20","doi-asserted-by":"publisher","unstructured":"Grech L, Kwok A, Nguyen M, Winkel A, Butler E, Allan M et al (2023) COVID-19 vaccine status, intent, hesitancy, and Disease-related beliefs in people with multiple sclerosis. Vaccines (Basel) 11. https:\/\/doi.org\/10.3390\/vaccines11020410","DOI":"10.3390\/vaccines11020410"},{"key":"8017_CR21","doi-asserted-by":"publisher","first-page":"e908","DOI":"10.1212\/WNL.0000000000008012","volume":"93","author":"A Hapfelmeier","year":"2019","unstructured":"Hapfelmeier A, Gasperi C, Donnachie E, Hemmer B (2019) A large case-control study on vaccination as risk factor for multiple sclerosis. Neurology 93:e908\u2013e16. https:\/\/doi.org\/10.1212\/WNL.0000000000008012","journal-title":"Neurology"},{"key":"8017_CR22","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1177\/13524585231199084","volume":"29","author":"S Darvishi","year":"2023","unstructured":"Darvishi S, Donnachie E, Gasperi C, Hapfelmeier A, Hemmer B (2023) Vaccination frequency in people newly diagnosed with multiple sclerosis. Mult Scler 29:1831\u20131840. https:\/\/doi.org\/10.1177\/13524585231199084","journal-title":"Mult Scler"},{"key":"8017_CR23","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/S2665-9913(23)00066-8","volume":"5","author":"P Sen","year":"2023","unstructured":"Sen P, Nune RN, Day A, Joshi J, Agarwal M V, et al (2023) Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune diseases (COVAD) study. Lancet Rheumatol 5:e247\u2013e50. https:\/\/doi.org\/10.1016\/S2665-9913(23)00066-8","journal-title":"Lancet Rheumatol"},{"key":"8017_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/13524585231218149","volume":"30","author":"L Jeantin","year":"2024","unstructured":"Jeantin L, Januel E, Labauge P, Maillart E, de Seze J, Zephir H et al (2024) COVID-19 outcomes in patients with multiple sclerosis: understanding changes from 2020 to 2022. Mult Scler 30:381\u2013395. https:\/\/doi.org\/10.1177\/13524585231218149","journal-title":"Mult Scler"},{"key":"8017_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00415-023-12034-0","volume":"271","author":"M Di Filippo","year":"2024","unstructured":"Di Filippo M, Ferraro D, Ragonese P, Prosperini L, Maniscalco GT, Gallo A et al (2024) SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. J Neurol 271:24\u201331. https:\/\/doi.org\/10.1007\/s00415-023-12034-0","journal-title":"J Neurol"},{"key":"8017_CR26","doi-asserted-by":"publisher","first-page":"1045101","DOI":"10.3389\/fimmu.2022.1045101","volume":"13","author":"M Pugliatti","year":"2022","unstructured":"Pugliatti M, Hartung HP, Oreja-Guevara C, Pozzilli C, Airas L, Alkhawajah M et al (2022) Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: lessons learnt a year in. Front Immunol 13:1045101. https:\/\/doi.org\/10.3389\/fimmu.2022.1045101","journal-title":"Front Immunol"},{"key":"8017_CR27","doi-asserted-by":"publisher","unstructured":"Inojosa H, Schriefer D, Atta Y, Dillenseger A, Proschmann U, Schleussner K et al (2024) Insights from real-world practice: the dynamics of SARS-CoV-2 infections and vaccinations in a large German multiple sclerosis cohort. Vaccines (Basel) 12. https:\/\/doi.org\/10.3390\/vaccines12030265","DOI":"10.3390\/vaccines12030265"},{"key":"8017_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fpubh.2020.00361","volume":"8","author":"N Principi","year":"2020","unstructured":"Principi N, Esposito S (2020) Do vaccines have a role as a cause of Autoimmune neurological syndromes? Front Public Health 8:361. https:\/\/doi.org\/10.3389\/fpubh.2020.00361","journal-title":"Front Public Health"},{"key":"8017_CR29","doi-asserted-by":"publisher","first-page":"e23944","DOI":"10.1016\/j.heliyon.2023.e23944","volume":"10","author":"F Ning","year":"2024","unstructured":"Ning F, Cao XQ, Wang QQ, Li ZY, Ruan Z, Chang T (2024) Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: a systematic review and meta-analysis. Heliyon 10:e23944. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23944","journal-title":"Heliyon"},{"key":"8017_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/hec.4781","volume":"33","author":"A Steinmayr","year":"2024","unstructured":"Steinmayr A, Rossi M (2024) Vaccine-skeptic physicians and patient vaccination decisions. Health Econ 33:509\u2013525. https:\/\/doi.org\/10.1002\/hec.4781","journal-title":"Health Econ"},{"key":"8017_CR31","doi-asserted-by":"publisher","first-page":"1139371","DOI":"10.3389\/fepid.2023.1139371","volume":"3","author":"JE Meador","year":"2023","unstructured":"Meador JE, James W, Branson J, Bennett J, Matthews K (2023) COVID-19 pandemic and the social determinants of health. Front Epidemiol 3:1139371. https:\/\/doi.org\/10.3389\/fepid.2023.1139371","journal-title":"Front Epidemiol"},{"key":"8017_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/WCO.0000000000001158","volume":"36","author":"BLC Piamonte","year":"2023","unstructured":"Piamonte BLC, Easton A, Wood GK, Davies NWS, Granerod J, Michael BD et al (2023) Addressing vaccine-preventable encephalitis in vulnerable populations. Curr Opin Neurol 36:185\u2013197. https:\/\/doi.org\/10.1097\/WCO.0000000000001158","journal-title":"Curr Opin Neurol"},{"key":"8017_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jama.2023.27428","volume":"331","author":"E Harris","year":"2024","unstructured":"Harris E (2024) CDC Warns of Low Vaccination Rates amid Spike in Respiratory diseases. JAMA 331:384. https:\/\/doi.org\/10.1001\/jama.2023.27428","journal-title":"JAMA"},{"key":"8017_CR34","doi-asserted-by":"publisher","first-page":"ofae154","DOI":"10.1093\/ofid\/ofae154","volume":"11","author":"N Nampota-Nkomba","year":"2024","unstructured":"Nampota-Nkomba N, Keita AM, Juma J, Sidibe D, Kourouma N, Sissoko S et al (2024) An upsurge of Measles cases in Mali-a consequence of pandemic-associated disruption in routine immunization. Open Forum Infect Dis 11:ofae154. https:\/\/doi.org\/10.1093\/ofid\/ofae154","journal-title":"Open Forum Infect Dis"},{"key":"8017_CR35","unstructured":"Garcia A Measles outbreak 2024, why measles is back in the US, and FDA approved OTC birth control pills 2024 [Available from: https:\/\/www.ama-assn.org\/delivering-care\/public-health\/measles-outbreak-2024-why-measles-back-us-and-fda-approved-otc-birth"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08017-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:49:40Z","timestamp":1742320180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08017-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["8017"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08017-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this anonymized online survey study according to Austrian regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors are members of the NeuroCOVID-19 Task Force of the European Academy of Neurology. No further competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}